Clinically Significant Unclassified Variants in BRCA1 and BRCA2 Genes among Korean Breast Cancer Patients
Cancer Research and Treatment. 2017;49(3):627-634 
Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2using five methods: results from a population-based study of young breast cancer patients
Breast Cancer Research. 2008;10(1):
BRCA1, BRCA2, BRCA3… A myriad of breast cancer genes
European Journal of Cancer. 1994;30(12):1738-1739
Expression and function of BRCA1 and BRCA2 in familial and sporadic breast cancer
Histopathology. 1999;34(2):170-174
Hereditary breast cancer – a spectrum of pathogenic mutations and unknown variants of BRCA1 and BRCA2 genes in the Czech Republic: efficiency of testing and clinical follow-up
Breast Cancer Research. 2005;7(S2):
Prevalence of BRCA1 and BRCA2 Mutations in Male Breast Cancer Patients in Canada
Clinical Breast Cancer. 2000;1(1):57-63
Commentary on “Prevalence of BRCA1 and BRCA2 Mutations in Male Breast Cancer Patients in Canada”
Clinical Breast Cancer. 2000;1(1):64-65
Hereditary Risk of Breast and Ovarian Cancer: BRCA1 and BRCA2
Encyclopedia of Cancer. 2002;381-385
Editorial: BRCA1 and BRCA2 genes mutations screening in sporadic breast cancer patients in Kazakhstan
Central Asian Journal of Global Health. 2013;2(1):
Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: A WECARE Study Report
Breast Diseases: A Year Book Quarterly. 2014;25(1):82-84